Biotech

Latest Articles

Cassava spends $40M over purportedly confusing Alzheimer's update

.Cassava Sciences has consented to spend $40 million to address an examination right into claims it ...

Merck bags options on Evaxion's AI-designed vaccination candidates

.Merck &amp Co. has grabbed alternatives on 2 Evaxion Biotech vaccine candidates, paying out $3.2 th...

Enanta's RSV antiviral crushes virus-like tons in challenge research

.Enanta Pharmaceuticals has linked its respiratory system syncytial virus (RSV) antiviral to notable...

Biogen containers SAGE-324 collaboration after necessary trembling neglect

.Biogen has carried out the last rites to its own cooperation with Sage Therapeutics on SAGE-324, ju...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout scores

.On the very same day that some Parkinson's disease drugs are actually being actually brought into q...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund from Bain Resources Lifestyle Sciences, Arch Venture Partners is ...

Orion to utilize Aitia's 'electronic doubles' to find new cancer medicines

.Finnish biotech Orion has actually spied prospective in Aitia's "electronic identical twin" tech to...

Windtree's shock med increases blood pressure in most up-to-date period 2 succeed

.While Windtree Therapies has actually strained to grow the monetary roots needed to have to survive...

2 cancer cells biotechs combine, developing global footprint

.OncoC4 is taking AcroImmune-- and also its in-house medical production functionalities-- under its ...

Amgen records initial period 3 win for $400M dermatitis medication

.Amgen has actually shared (PDF) the first phase 3 data on its $400 thousand chronic eczema medicati...

Biogen, UCB document phase 3 lupus win after stopping working earlier test

.Biogen and also UCB's bank on improving right into phase 3 on the back of an unsuccessful research ...

Aptadir wishes brand-new RNA preventions can reverse complicated cancers

.Italian biotech Aptadir Rehabs has actually introduced along with the promise that its pipeline of ...

Wave surfs DMD success to regulators' doors, delivering stock up

.Wave Life Sciences has met its own target in a Duchenne muscle dystrophy (DMD) study, positioning i...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, taking ...

Achilles drops tissue therapy program, bandages for unemployments after missing out on 'commercial stability' targets

.Achilles Therapies has wrecked its own method. The British biotech is actually knocking off on its ...

Aligos declares phase 2 MASH win, reducing liver fat approximately 46%

.Aligos Therapeutics is heralding a midstage win in metabolic-dysfunction linked steatohepatitis (MA...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work establishing brand new antifungals has actually received a considerabl...

Capricor markets Europe rights to late-stage DMD therapy for $35M

.Having actually scooped up the U.S. civil liberties to Capricor Rehabs' late-stage Duchenne muscula...

FDA junks adcomm for Applied's rare disease medication

.After pushing the decision meeting for Applied Therapies' metabolic problem medicine govorestat, th...

Novo inks $600M NanoVation bargain to study genetic drugs ex-liver

.Novo Nordisk is actually proceeding its own push into hereditary medicines, consenting to compensat...